Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Urology Practice
|
June 15, 2023
Robotic Pyeloplasty in Patients with Equivocal Diuretic Renogram
Andrew W Stamm, Sydney Akapame, Sharon Durfy, et al.
The Patient
|
January 10, 2018
Impact of Canagliflozin Treatment on Health-Related Quality of Life among People with Type 2 Diabetes Mellitus: A Pooled Analysis of Patient-Reported Outcomes from Randomized Controlled Trials
Jennifer Cai, Linda M Delahanty, Sydney Akapame, et al.
Urology
|
February 26, 2019
AUTHOR REPLY
Andrew W Stamm, Sydney Akapame, Sharon Durfy, et al.
Urology Practice
|
June 14, 2023
Increasing Adherence to an AUA Guideline: A Durable Impact on Immediate Postoperative Mitomycin C Use
Andrew Stamm, Ryan Donahue, Kathryn Dahl, et al.
Urology
|
December 12, 2018
Outcomes after Robotic-assisted Pyeloplasty in Patients Presenting with Pain Versus Nonpain Presenting Symptoms
Andrew W Stamm, Sydney Akapame, Sharon Durfy, et al.
Clinical Pharmacology in Drug Development
|
July 24, 2024
Effect of Erdafitinib on the Pharmacokinetics of Midazolam and Metformin in Patients With Advanced Solid Tumors Harboring FGFR Gene Alterations
Wei Zhu, Mahadi Baig, Vahid Naini, et al.
Journal of Clinical Lipidology
|
February 8, 2018
Relations of GlycA and lipoprotein particle subspecies with cardiovascular events and mortality: A post hoc analysis of the AIM-HIGH trial
James D Otvos, John R Guyton, Margery A Connelly, et al.
The Canadian Journal of Urology
|
August 24, 2017
A decision aid versus shared decision making for prostate cancer screening: results of a randomized, controlled trial
Andrew W Stamm, John S Banerji, Erika M Wolff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 15, 2026
Erdafitinib or Erdafitinib Plus Cetrelimab for Patients With Metastatic Urothelial Carcinoma and <i>FGFR</i> Alterations: Final Results From the Phase II NORSE Study
Yohann Loriot, Thomas Powles, Victor Moreno, et al.
The New England Journal of Medicine
|
October 23, 2023
Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma
Yohann Loriot, Nobuaki Matsubara, Se Hoon Park, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Urology Practice
|
June 15, 2023
Robotic Pyeloplasty in Patients with Equivocal Diuretic Renogram
Andrew W Stamm, Sydney Akapame, Sharon Durfy, et al.
The Patient
|
January 10, 2018
Impact of Canagliflozin Treatment on Health-Related Quality of Life among People with Type 2 Diabetes Mellitus: A Pooled Analysis of Patient-Reported Outcomes from Randomized Controlled Trials
Jennifer Cai, Linda M Delahanty, Sydney Akapame, et al.
Urology
|
February 26, 2019
AUTHOR REPLY
Andrew W Stamm, Sydney Akapame, Sharon Durfy, et al.
Urology Practice
|
June 14, 2023
Increasing Adherence to an AUA Guideline: A Durable Impact on Immediate Postoperative Mitomycin C Use
Andrew Stamm, Ryan Donahue, Kathryn Dahl, et al.
Urology
|
December 12, 2018
Outcomes after Robotic-assisted Pyeloplasty in Patients Presenting with Pain Versus Nonpain Presenting Symptoms
Andrew W Stamm, Sydney Akapame, Sharon Durfy, et al.
Clinical Pharmacology in Drug Development
|
July 24, 2024
Effect of Erdafitinib on the Pharmacokinetics of Midazolam and Metformin in Patients With Advanced Solid Tumors Harboring FGFR Gene Alterations
Wei Zhu, Mahadi Baig, Vahid Naini, et al.
Journal of Clinical Lipidology
|
February 8, 2018
Relations of GlycA and lipoprotein particle subspecies with cardiovascular events and mortality: A post hoc analysis of the AIM-HIGH trial
James D Otvos, John R Guyton, Margery A Connelly, et al.
The Canadian Journal of Urology
|
August 24, 2017
A decision aid versus shared decision making for prostate cancer screening: results of a randomized, controlled trial
Andrew W Stamm, John S Banerji, Erika M Wolff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 15, 2026
Erdafitinib or Erdafitinib Plus Cetrelimab for Patients With Metastatic Urothelial Carcinoma and <i>FGFR</i> Alterations: Final Results From the Phase II NORSE Study
Yohann Loriot, Thomas Powles, Victor Moreno, et al.
The New England Journal of Medicine
|
October 23, 2023
Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma
Yohann Loriot, Nobuaki Matsubara, Se Hoon Park, et al.
Page
of 2